Daniel Schiwek demonstrates the value of Gyrolab in HCP analysis and bioprocess

Daniel Schiwek, Project Evaluation Manager at Global Biological Operations, Lonza AG,Visp, Switzerland, presented ‘Biopharmaceutical manufacturing in microbial systems – Gyrolab™ as an analytical platform supporting process development’ at the Gyrolab Seminar, 2011, held in Siena, Italy.

Gyrolab workstation was compared with ELISA for HCP analysis and delivered:

  • Faster assay development times
  • Reduced consumption of reagents and samples
  • Reduced matrix effects (lower sample dilution)
  • Increased dynamic range

You can find out more about this work in the poster by Peiris and Schiwek : Download


Note: To view the presentation on full screen, press ‘full screen’ before starting the presentation. Use ‘Outline’ to view selected sections of the presentation.